Abstract
BackgroundThe optimal therapeutic approach for lupus nephritis (LN) involves an induction phase to achieve remission followed by maintenance therapy to prevent relapses. Mycophenolate mofetil (MMF) has become the primary induction...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
